BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
0.9156
+0.0153 (1.70%)
May 28, 2026, 2:22 PM EDT - Market open
BioCardia Market Cap
BioCardia has a market cap or net worth of $10.41 million as of May 28, 2026. Its market cap has decreased by -27.91% in one year.
Market Cap
10.41M
Enterprise Value
9.70M
1-Year Change
-27.91%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $10.41M, a decrease of -64.18%. That is a compound annual growth rate of -10.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 10.24M | -22.80% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 11.55M |
| Lunai Bioworks | 11.47M |
| BioRestorative Therapies | 11.38M |
| BioVie | 10.94M |
| Aprea Therapeutics | 10.84M |
| Kairos Pharma | 10.82M |
| Jupiter Neurosciences | 10.42M |
| Soligenix | 10.31M |